✦ LIBER ✦

144 Phase III study of docetaxel and irinotecan (CPT-11) for previously untreated advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Kudoh, S.; Negoro, S.; Masuda, N.; Sugiura, T.; Shimokata, H.; Fukuoka, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of CPT-11, new camptothec

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I study of cisplatin, docetaxel an

✍ Kiura, K; Ueoka, H; Eguchi, K; Segawa, Y; Takigawa, N; Kamei, H; Shibayama, T; H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Phase I study of vinorelbine and irinote

✍ Nanae Tomonaga; Yoichi Nakamura; Hiroshi Soda; Seiji Nagashima; Hirofumi Nakano; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 273 KB

Phase II trial of weekly docetaxel and g

✍ Park, Se Hoon; Hong, Junshik; Kim, Young Saing; Kim, Yujin; Kyung, Sun Young; An 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase I study of irinotecan (CPT-11) and

✍ Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbaki 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 96 KB